Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Genome Therapeutics and Astra Research Center Boston extend alliance

June 17, 1998

ISIS-2302 exhibits promising activity in phase II study for Crohn's disease

June 17, 1998

Shiseido presents antisecretory/antibacterial agents for ulcers

June 16, 1998

Isis and Merck & Co. establish collaboration for hepatitis C

June 15, 1998

Protein Design Labs' human antihepatitis B antibody enters phase IIa

June 12, 1998

Maxamine plus IFN-alpha appears effective and safe in nonresponding HCV patients

June 11, 1998

First European clearance for Eisai's Pariet

June 11, 1998

Rebetron now available in the U.S.

June 9, 1998

Chinese herbal medicine reduces ALT levels in chronic hepatitis C

June 8, 1998

Zadaxin shows efficacy and safety in phase III trial for hepatitis B

June 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...